ATNM Stock Price Comparison to Moving Averages:
USA based company, Actinium Pharmaceuticals, Inc.’s (ATNM)’s latest closing price distance was at -6.38% from the average-price of 200 days while it maintained a distance from the 50 Day Moving Average at 36.81% and 33.70% compared with the 20 Day Moving Average.
Analysts Mean Rating:
Analysts’ mean recommendation for Actinium Pharmaceuticals, Inc.’s (ATNM) stands at 1.50. Rating Scale; where 1.0 rating means Strong Buy, 2.0 rating signify Buy, 3.0 recommendation reveals Hold, 4.0 rating score shows Sell and 5.0 displays Strong Sell signal.
To review the ATNM previous performance, look at its past history, which highlighted below:
During last 5 trades the stock sticks almost 28.30%.
During last one month it showed the change of 43.11%.
During last 3 month it remained at 46.24%.
Along with these its year to date performance is standing at 55.43%.
Important Technical Indicators:
ATR value of company was 0.08. Relative Strength Index (RSI) was 74.98. Developed J. Welles Wilder, the Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. RSI oscillates between zero and 100. Traditionally, and according to Wilder, RSI is considered overbought when above 70 and oversold when below 30. Signals can also be generated by looking for divergences, failure swings and centerline crossovers. RSI can also be used to identify the general trend.
The stock volatility for week was 8.85% while for month was 7.09%.The stock, as of last close, traded 58.14% to its 52 week low and was changed -42.37% from its 52 week high. Beta factor, which measures the riskiness of the security, was observed as 1.62. ATNM’s value Change from Open was at 27.10% with a Gap of 3.88%.
Earnings per share Details about ATNM:
EPS growth in next year is estimated to reach 27.10% while EPS growth estimate for this year is set at 38.90%.
Actinium Pharmaceuticals, Inc.’s (ATNM)’s Stock Price Trading Update:
Actinium Pharmaceuticals, Inc.’s (ATNM), a part of Healthcare sector and belongs to Biotechnology industry; ended its day with a gain of 32.04% and finalized at the price of $1.36. During its last trading session, Stock traded with the total exchanged volume of 5.51 million shares. The average volume stands around 0.27 million shares. The average numbers of shares are traded in a security per day, during the recent 3-month period. The stock has relative volume of 20.11. Relative volume is ratio between current volume and 3-month average value, intraday adjusted.
Analysts are estimating that Actinium Pharmaceuticals, Inc. (ATNM) to hit $7.00 Price Target in next one year, this mean price is come up through the consensus of analysts. The Median price target for the stock is set at $7.00. Highest potential price target is expected at $9.00 however minimum price target advised by analysts is $5.00. A price target is the projected price level of a financial security stated by an investment analyst or advisor. It represents a security’s price that, if achieved, results in a trader recognizing the best possible outcome for his investment. Essentially, a price target is an individual analyst’s expectation on the future price of a security, usually a stock. There may be many price targets for a single security. An influential analyst on Wall Street may give a stock that is currently trading at $60 a one-year price target of $90; however, there is no concrete way to calculate a price target. Different analysts and financial institutions use various valuation methods and take into account different economic forces when deciding on a price target.